|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | |||||
RESEARCH ARTICLE |
Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, New Haven, CT 06520-8066, USA
*Author for correspondence (e-mail: anton.Bennett{at}yale.edu)
Accepted March 13, 2001
Myogenesis is a highly ordered process that involves the expression of muscle-specific genes, cell-cell recognition and multinucleated myotube formation. Although protein tyrosine kinases have figured prominently in myogenesis, the involvement of tyrosine phosphatases in this process is unknown. SHP-2 is an SH2 domain-containing tyrosine phosphatase, which positively regulates growth and differentiation. We show that in C2C12 myoblasts, SHP-2 becomes upregulated early on during myogenesis and associates with a 120 kDa tyrosyl-phosphorylated complex. We have identified that the 120 kDa complex consists of the SHP-2 substrate-1 (SHPS-1) and the Grb2-associated binder-1 (Gab-1). SHPS-1, but not Gab-1, undergoes tyrosyl phosphorylation and association with SHP-2 during myogenesis, the kinetics of which correlate with the expression of MyoD. Either constitutive expression or inducible activation of MyoD in 10T
fibroblasts promotes SHPS-1 tyrosyl phosphorylation and its association with SHP-2. It has been shown that p38 mitogen-activated protein kinase (MAPK) activity is required for the expression/activation of MyoD and MyoD-responsive genes. Inhibition of p38 MAPK by SB203580 in differentiating C2C12 myoblasts blocks MyoD expression, SHPS-1 tyrosyl phosphorylation and the association of SHPS-1 with SHP-2. These data suggest that SHPS-1/SHP-2 complex formation is an integral signaling component of skeletal muscle differentiation.
Key words: SHP-2, Tyrosine phosphatase, Myogenesis, Signalling, Myoblast, SHPS-1
This article has been cited by other articles:
![]() |
T. Koyama, Y. Nakaoka, Y. Fujio, H. Hirota, K. Nishida, S. Sugiyama, K. Okamoto, K. Yamauchi-Takihara, M. Yoshimura, S. Mochizuki, et al. Interaction of Scaffolding Adaptor Protein Gab1 with Tyrosine Phosphatase SHP2 Negatively Regulates IGF-I-dependent Myogenic Differentiation via the ERK1/2 Signaling Pathway J. Biol. Chem., August 29, 2008; 283(35): 24234 - 24244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eminaga and A. M. Bennett Noonan Syndrome-associated SHP-2/Ptpn11 Mutants Enhance SIRP{alpha} and PZR Tyrosyl Phosphorylation and Promote Adhesion-mediated ERK Activation J. Biol. Chem., May 30, 2008; 283(22): 15328 - 15338. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Wadley, N. Konstantopoulos, L. Macaulay, K. F. Howlett, A. Garnham, M. Hargreaves, and D. Cameron-Smith Increased insulin-stimulated Akt pSer473 and cytosolic SHP2 protein abundance in human skeletal muscle following acute exercise and short-term training J Appl Physiol, April 1, 2007; 102(4): 1624 - 1631. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fornaro, P. M. Burch, W. Yang, L. Zhang, C. E. Hamilton, J. H. Kim, B. G. Neel, and A. M. Bennett SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth J. Cell Biol., October 9, 2006; 175(1): 87 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Kontaridis, S. Eminaga, M. Fornaro, C. I. Zito, R. Sordella, J. Settleman, and A. M. Bennett SHP-2 Positively Regulates Myogenesis by Coupling to the Rho GTPase Signaling Pathway Mol. Cell. Biol., June 15, 2004; 24(12): 5340 - 5352. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. M. Ruhul Amin, M. L. Oo, T. Senga, N. Suzuki, G.-S. Feng, and M. Hamaguchi SH2 Domain Containing Protein Tyrosine Phosphatase 2 Regulates Concanavalin A-dependent Secretion and Activation of Matrix Metalloproteinase 2 via the Extracellular Signal-regulated Kinase and p38 Pathways Cancer Res., October 1, 2003; 63(19): 6334 - 6339. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Yusa and K. S. Campbell Src Homology Region 2-Containing Protein Tyrosine Phosphatase-2 (SHP-2) Can Play a Direct Role in the Inhibitory Function of Killer Cell Ig-Like Receptors in Human NK Cells J. Immunol., May 1, 2003; 170(9): 4539 - 4547. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Kontaridis, X. Liu, L. Zhang, and A. M. Bennett Role of SHP-2 in Fibroblast Growth Factor Receptor-Mediated Suppression of Myogenesis in C2C12 Myoblasts Mol. Cell. Biol., June 1, 2002; 22(11): 3875 - 3891. [Abstract] [Full Text] [PDF] |
||||